International Guidelines for the Diagnosis and Management of Hyperinsulinism
Hormone Research in Paediatrics · 2024 · 97 (3) · 279-298
DOI: 10.1159/000531766 ↗Kurz gefasst
Leitlinie in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 14.07.2023. Verfasst von Diva D De Leon und 16 weiteren Autor:innen. Beteiligte Einrichtung: Congenital Hyperinsulinism Center and Division of Endocrinology and Diabetes, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman…. Hauptthemen laut MEDLINE: Congenital Hyperinsulinism. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Wellcome Trust.
Abstract (Originalsprache)
Background: Hyperinsulinism (HI) due to dysregulation of pancreatic beta-cell insulin secretion is the most common and most severe cause of persistent hypoglycemia in infants and children. In the 65 years since HI in children was first described, there has been a dramatic advancement in the diagnostic tools available, including new genetic techniques and novel radiologic imaging for focal HI; however, there have been almost no new therapeutic modalities since the development of diazoxide. Summary: Recent advances in neonatal research and genetics have improved our understanding of the pathophysiology of both transient and persistent forms of neonatal hyperinsulinism. Rapid turnaround of genetic test results combined with advanced radiologic imaging can permit identification and localization of surgically-curable focal lesions in a large proportion of children with congenital forms of HI, but are only available in certain centers in “developed” countries. Diazoxide, the only drug currently approved for treating HI, was recently designated as an “essential medicine” by the World Health Organization but has been approved in only 16% of Latin American countries and remains unavailable in many under-developed areas of the world. Novel treatments for HI are emerging, but they await completion of safety and efficacy trials before being considered for clinical use. Key Messages: This international consensus statement on diagnosis and management of HI was developed in order to assist specialists, general pediatricians, and neonatologists in early recognition and treatment of HI with the ultimate aim of reducing the prevalence of brain injury caused by hypoglycemia. A previous statement on diagnosis and management of HI in Japan was published in 2017. The current document provides an updated guideline for management of infants and children with HI and includes potential accommodations for less-developed regions of the world where resources may be limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Congenital Hyperinsulinism Center and Division of Endocrinology and Diabetes, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, P…
- Reference Center for Inherited Metabolic Diseases, Necker-Enfants Malades Hospital, AP-HP, University of Paris-Cité, Paris, France.
- Paediatric Endocrinology, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
- Centro de Investigaciones Endocrinológicas "Dr. César Bergadá" (CONICET - FEI), Division de Endrocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina.
- Department of Clinical Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Australia and Children's Health Queensland Clinical Unit, Department of Endocrinology and Diabetes, Queensland Children's Hospital, Children's Health Queensland, Greater Brisbane Clinical School, Medical School, Faculty…
Förderung
- NIDDK NIH HHS
- Wellcome Trust
Zitieren
APA
De Leon, D. D., Arnoux, J. B., Banerjee, I., Bergada, I., Bhatti, T., Conwell, L. S., Fu, J., Flanagan, S. E., Gillis, D., Meissner, T., Mohnike, K., Pasquini, T. L. S., Shah, P., Stanley, C. A., Vella, A., Yorifuji, T., & Thornton, P. S. (2024). International Guidelines for the Diagnosis and Management of Hyperinsulinism. Hormone Research in Paediatrics, 97(3), 279-298. https://doi.org/10.1159/000531766
Vancouver
De Leon DD, Arnoux JB, Banerjee I, Bergada I, Bhatti T, Conwell LS, et al. International Guidelines for the Diagnosis and Management of Hyperinsulinism. Hormone Research in Paediatrics. 2024;97(3):279-298. doi:10.1159/000531766
BibTeX
@article{DeLeon2024,
author = {De Leon, Diva D and Arnoux, Jean Baptiste and Banerjee, Indraneel and Bergada, Ignacio and Bhatti, Tricia and Conwell, Louise S and Fu, Junfen and Flanagan, Sarah E and Gillis, David and Meissner, Thomas and Mohnike, Klaus and Pasquini, Tai L S and Shah, Pratik and Stanley, Charles A and Vella, Adrian and Yorifuji, Tohru and Thornton, Paul S},
title = {International Guidelines for the Diagnosis and Management of Hyperinsulinism},
journal = {Hormone Research in Paediatrics},
year = {2024},
volume = {97},
number = {3},
pages = {279--298},
doi = {10.1159/000531766}
}
EUVIMED